Clinical Trial Update: Study of Long-Acting Injectable Naltrexone to Treat Cannabis Dependence [Phase 1, Phase 2]

View source ↗

Summary

A study evaluating a long-acting injectable naltrexone for cannabis dependence has completed Phase 1 and Phase 2 trials with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cannabis Dependence
• Cannabis Use Disorder

Drugs mentioned

• Long-acting injectable naltrexone (naltrexone)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Cannabis Dependence | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-08-18